Objectives: To determine risk factors associated with admission to a PICU with or without endotracheal intubation for an asthma exacerbation. We hypothesized that children with critical and nearfatal asthma would have distinguishing clinical features but varying degrees of asthma severity and measures of type 2 inflammation. Design: Retrospective analysis of prospectively collected data of children with asthma recruited into outpatient asthma clinical research studies at Emory University between 2004 and 2015. Setting: Large, free-standing academic quaternary care children's hospital in Atlanta, GA. Patients: Children 6-18 years old with physician-diagnosed and confirmed asthma. Interventions: None. Measurements and Main Results: A total of 579 children were analyzed with 170 children (29.4%) being admitted to the PICU for an asthma exacerbation in their lifetime. Of these 170 children with a history of critical asthma, 24.1% were classified as having mild-to-moderate asthma, and 83 of 170 children (48.8%) had been intubated and experienced near-fatal asthma. Multiple logistic regression was used to identify risk factors associated with increased odds of PICU admission with or without endotracheal intubation. Hospitalization within the prior 12 months of survey (odds ratio, 8.19; 95% CI,), a history of pneumonia (odds ratio, 2.56; 95% CI, 1.52-4.29), having a designation of increased chronic asthma severity on high-dose inhaled corticosteroids (odds ratio, 2.76; 95% CI, 1.62-4.70), having a father with asthma (odds ratio, 2.15; 95% CI, 1.23-3.76), living in a region with a higher burden of poverty (odds ratio, 1.28; 95% CI, 1.02-1.61), and being of black race (odds ratio, 2.01; 95% CI, 1.05-3.84) were all associated with increased odds of PICU admission with or without intubation. Conclusions: Our findings suggest that there are factors associated with critical and near-fatal asthma, distinct from the chronic asthma severity designations, that should be the focus of future investigation. (Pediatr Crit Care Med 2018; 19:e585-e594) 
O ver 6 million children less than 18 years old are currently diagnosed with asthma, and most of these children are poorly controlled despite therapy attempts (1) . Asthma exacerbation is therefore the leading medical emergency in children, with critical asthma responsible for up to 20% of all admissions to PICUs (2) (3) (4) . Some children with critical asthma require endotracheal intubation and mechanical ventilation, a condition termed "near-fatal asthma" (5) . Although the current National Institutes of Health/National Heart, Lung, and Blood Institute guidelines propose criteria for asthma severity based on symptoms and medication responses, these guidelines do not delineate features of critical or near-fatal asthma (6) . Indeed, many children classified as having intermittent or mild persistent asthma are hospitalized with critical and/or near-fatal asthma exacerbations (7) .
Attempts at characterizing critical asthma phenotypes have been limited by incomplete characterization of clinical features including lung function, medication use, and inflammatory biomarkers. Therefore, it is unclear what features are associated with critical asthma in children, and whether these features can be identified in children in outpatient settings. Characterization of the molecular and cellular patterns of airway inflammation in children with asthma is not routine. Whereas some investigators have found increased allergic eosinophilic airway responses characterized by type 2 inflammatory cytokines interleukin (IL)-4, IL-5, and IL-13 (8, 9) , others have discovered neutrophilic, mixed neutrophil-eosinophil, and paucigranular patterns of airway inflammation (10, 11) . High numbers of airway neutrophils are associated with type 1 inflammation characterized by infection-fighting cytokines IL-2 and interferon-γ that are resistant to corticosteroid therapy (11) (12) (13) . To address this knowledge gap, we compared the characteristics of children with critical and near-fatal asthma to children without critical asthma in a large dataset of well-phenotyped children with asthma. We hypothesized that children with critical and near-fatal asthma would have distinguishing clinical features but varying degrees of asthma severity and measures of type 2 inflammation. We further hypothesized that a subset of children with critical and near-fatal asthma would have associated frequent pulmonary infections.
METHODS
We conducted a retrospective analysis of children 6-18 years old with physician-diagnosed asthma recruited into outpatient asthma clinical research studies at Emory University between January 01, 2004, and December 31, 2015. Children with any historical admission to a PICU with or without need for endotracheal intubation for status asthmaticus were compared with children without a prior PICU admission. Admission criteria were consistent for the duration of the study period and included 1) need for a third continuous nebulized albuterol treatment and/or 2) need for noninvasive respiratory support delivered by high-flow nasal-cannula or bi-level positive airway pressure and/or 3) need to deliver an 80%/20% heliox mixture and/or 4) need to deliver greater than or equal to 50% Fio 2 by Venturi mask or positive pressure ventilation strategies. Hospitalization or emergency department use within the 12 months prior to study enrollment were used to define healthcare use.
Participants
All children who underwent standardized characterization in research protocols were eligible for inclusion (14, 15) . These protocols were approved by Emory University's Institutional Review Board. Written informed consent was obtained from the legal guardians of each child, and verbal and written assent were obtained from the participating child for the original study for which data were acquired.
Eligible children had never smoked, had physician-diagnosed asthma along with a history of greater than or equal to 12% relative change in forced expiratory volume in 1 second (FEV1) after bronchodilator administration. Children were classified as having severe asthma according to the American Thoracic Society workshop criteria (16) . This definition assumes that comorbid conditions have been treated or addressed and that the child is adherent with prescribed asthma treatment. Thresholds for high-dose inhaled corticosteroids (ICS) were defined as an inhaled fluticasone equivalent greater than 800 µg if greater than or equal to 12 years or greater than 400 µg if less than 12 years old. Original study exclusion criteria included birth prior to 35 weeks of gestation, a history of developmental delay, or an asthma exacerbation treated with systemic corticosteroid within the 4 weeks prior to study enrollment. Children with steroid exposure were excluded to obtain true baseline spirometry, laboratory, and symptomatology data not confounded by their recent asthma exacerbation. Chronic neurologically impaired children were excluded from the study due to limitations in participation in spirometry testing. All children were stable at the time of characterization with no signs of acute respiratory illness. Children with an acute worsening of asthma control were treated and reassessed later.
Characterization Procedures
Participants underwent a battery of standardized phenotypic characterization procedures that included questionnaires, serum immunoglobulin E (IgE), and complete blood count with differential, allergy skin prick testing, and bronchial responsiveness to methacholine as previously described (17, 18) . Spirometry was performed with a portable spirometer (KoKo Legend; Ferraris, Louisville, CO). The best of three forced vital capacity maneuvers was interpreted according to population reference standards (19) . Exhaled nitric oxide (NIOX; Aerocrine, Solna, Sweden) was quantified using online methods (15) . Aeroallergen sensitization was defined as a positive skin prick test with wheal greater than or equal to 3 mm and flare greater than or equal to 10 mm in diameter or a specific aeroallergen IgE test greater than 0.35 kU/L. Community (i.e., ZIP code) characteristics were obtained from Tables S101 (Age and Sex), S1501 (Educational Attainment), and DP03 (Selected Economic Characteristics) of the 2010-2014 American Community Survey 5-year estimates, available at www.factfinder. census.gov (20) .
Statistical Analyses
Descriptive statistics were calculated for all variables of interest. Frequencies were calculated for categorical variables and reported as percentages. Means and sds or medians and interquartile ranges were calculated for continuous variables, where appropriate. Normality of the data was determined by Shapiro tests and visual inspection of histograms. Comparisons between intubated, PICU never intubated, and never PICU were performed using chi-square, analysis of variance, and KruskalWallis tests, where appropriate. Post hoc tests between PICU admitted versus never PICU, intubated versus never PICU, and intubated versus PICU never intubated were performed, and multiple comparisons were controlled for using Bonferroni corrections; p values were assessed at α equals to 0.05/3 equals to 0.017. Variables with multiple, mutually exclusive responses were tested with a single chi-square test. Variables with multiple, nonmutually exclusive responses were tested with individual chi-square tests assessing for the presence versus absence of each response. Multiple logistic regression models were used to identify primary factors associated with PICU admissions (21) . Candidate variables showed univariate associations of p value of less than 0.05, and forward selection was used to select the final model. Due to the concern of older patients having a Pediatric Critical Care Medicine www.pccmjournal.org e587 longer period to have had a PICU admission, an indicator variable for age greater than or equal to 12 years was forced into the final model. Only unique children were included in the dataset precluding the issue of coding for recurrent admissions. The same modeling strategy was used for the multinomial logistic regression model with the three-category outcome of intubated, PICU not intubated, and never PICU. Odds ratios were calculated for both PICU groups versus never PICU. Ordinal models were tested but did not meet the proportional odds assumption. Statistical analyses were performed with SAS Version 9.4 (SAS Institute, Cary, NC).
RESULTS
There were 580 total children identified in the database; however, one patient was missing ICU information, and 579 were included for the analysis. Of these children, 170 (29.4%) had been admitted to a PICU, excluding the neonatal period, for asthma in their lifetime. Of these 170 children with a history of critical asthma, 83 of 170 children (48.8%) had been intubated and experienced near-fatal asthma. The proportion of children with mild-to-moderate asthma in the never PICU patients was 235 of 409 (57.6%) versus 24 of 87 (27.6%) and 17 of 83 (20.5%) in the PICU never intubated versus intubated groups, respectively (p < 0.001) ( Table 1) . Children 12 years old and older were more likely to have been intubated compared with children under 12 years old (Table 1) . Black children predominated in our asthma cohort (58.0% vs 29.9% white and 12.1% other) and are overrepresented compared with the racial demographics of the Metro Atlanta, Georgia region (55.4% white, 32.4% black, 12.2% other). Intubated children were more likely to be black race than those not admitted to the PICU (80.7% vs 52.3%; p < 0.001) ( Table 1) . Children from socioeconomically disadvantaged communities were more likely to have been hospitalized in a PICU compared with children never hospitalized in a PICU (Table 1) .
Clinical Associations With PICU Admission and Endotracheal Intubation
Children admitted to a PICU had more frequent episodes of weekly and daily wheezing and weekly and daily night awakenings than children never in the PICU ( Table 2) . A history of pneumonia, gastroesophageal reflux disease, exposure to secondary indoor smoking, and a father with a history of asthma were all associated with a higher frequency of ICU admissions. There were no triggers of asthma exacerbations that were significantly different among groups after multiple comparisons ( Table 2 ). There were no significant differences between the children who had a history of intubation compared with the children admitted to the PICU and never intubated (Table 2) .
Medication, Healthcare Use, and Lung Function
As expected, children with a history of intubation (79.5%) or a PICU admission without intubation (72.4%) were more likely to use high-dose ICS compared with 42.4% of children never admitted to a PICU (p < 0.001) ( Table 3) . Likewise, children with a history of intubation (56.8%) or a history of PICU admission (48.3%) were more likely to use daily β-agonist medication (32.8%; p < 0.001). Combinations of medications such as ICS along with a long-acting β-agonist (LABA) and Montelukast or the use of Omalizumab were more commonly used in children intubated and/or in the PICU compared with children never in a PICU. Children with an intubation or PICU history were more likely to have been hospitalized or visited an emergency department in the previous year compared with children never in the PICU (Table 3) . Finally, children with a PICU history were more likely to have lower FEV1, regardless of intubation history, compared with children with asthma never admitted to a PICU (Table 3) .
Type 2 Inflammatory Markers by PICU Admission and Endotracheal Intubation
Children with a PICU admission history who were intubated were more likely to have a higher absolute eosinophil count than children never admitted to a PICU ( Table 4) . There was no difference in the number of aeroallergen skin prick responses or serum IgE levels. The median exhaled nitric oxide level was higher in children with a history of PICU admission without intubation or a history of PICU admission with intubation compared with children without PICU admission.
Multiple Variable Associations of PICU Admission and Endotracheal Intubation
We used multiple logistic regression to estimate the odds of being admitted to the PICU ( Table 5 ; and eTable 1, Supplemental Digital Content 1, http://links.lww.com/PCC/A732). Age was forced into the model as older children have a longer window of opportunity to be admitted to the PICU for an asthma exacerbation. We found that being admitted to the hospital for an asthma exacerbation in the 12 months prior to data collection was associated with increased odds of ever having been admitted to a PICU (odds ratio, 8.19; 95% CI, 4.83-13.89; p < 0.001) ( Table 5 ). Having a history of pneumonia was also correlated with increased odds of having had a PICU admission for an asthma exacerbation (odds ratio, 2.56; 95% CI, 1.52-4.29; p < 0.001) ( Table 5 ). Other factors related to increased odds of PICU admission for asthma included black race (odds ratio, 2.01; 95% CI, 1.05-3.84; p = 0.034), living in an area with a higher percentage of the residents having income below the poverty line (odds ratio, 1.28; 95% CI, 1.02-1.61; p = 0.037), having a father with a history of asthma (odds ratio, 2.15, 95% CI, 1.23-3.76; p = 0.007), or having a history of severe asthma or high corticosteroid use (odds ratio, 2.76; 95% CI, 1.62-4.70; p < 0.001) ( Table 5 ). We performed a sensitivity analysis with the model excluding severe asthma/high ICS use with similar odds ratios for the significant variables with the addition of the medication combination consisting of an ICS + a LABA + Montelukast with an odds of 1.97 (95% CI, 1.21-3. 
DISCUSSION
This study describes the clinical, lung function, inflammatory, and comorbid characteristics of critical and near-fatal asthma in a well-phenotyped cohort of children. We used multiple logistic regression to analyze the characteristics associated with increased odds of experiencing critical or near-fatal asthma.
Hospitalization within the prior 12 months for an asthma exacerbation was the factor most highly associated with increased odds of a PICU admission, a result consistent with a retrospective review of over 26,000 children ages 2-17 years from a pan-Canadian administrative database (22) . Other significant factors associated with increased odds of PICU admission included having a history of pneumonia, having a designation of increased chronic asthma severity on high-dose ICS, having a paternal history of asthma, living in a region with a higher burden of poverty, and being of non-Caucasian race. Designation of asthma severity is driven by chronic symptom severity and prescribed dose of ICS, and admission to a PICU for critical or near-fatal asthma likely drives prescription practice. Therefore, it is not surprising that the critical and nearfatal groups have the highest symptom and medication burden. There was, however, a sizeable percentage of children in our cohort defined as having mild or moderate asthma with critical asthma (27.6%) and near-fatal asthma (20.5%) ( Table 1) . By contrast, of the children categorized as having severe asthma, 42.4% had never been admitted to a PICU for an exacerbation. The mismatch between chronic asthma severity stratification and the tendency of some children with mild asthma to present with critical and near-fatal asthma has been reported in both children and adults (23, 24) . Similar to our findings, Carroll et al (23) noted that features associated with recurrent PICU admissions for severe asthma exacerbations were associated with a child being overweight, receiving public insurance, and not being Caucasian. Multiple PICU admissions and/or intubations were not assessed as part of the original study, and therefore we cannot analyze risk factors for recurrent critical and near-fatal asthma.
Although critical and near-fatal asthma are associated with asthma severity, we believe that critical and near-fatal asthma are distinct phenotypes. Characterization of this distinct phenotype is necessary not only to design interventions to prevent the occurrence of critical and near-fatal asthma but to identify a subgroup of children for which current therapies inadequately treat their asthma. These children may have distinct pathobiological mechanisms that would respond to alternative therapies.
The frequency of invasive mechanical ventilation has been reported to range from 10% to 12% in a retrospective (25) . The frequency of invasive mechanical ventilation in our cohort (83/409; 20%) is not the true occurrence rate of nearfatal asthma at our center as there is selection bias for children recruited from high-risk asthma and allergy clinics who are likely more motivated to participate in a research study following near-fatal asthma. Likewise, only a small percentage of children admitted to our PICU with asthma are invasively mechanically ventilated compared with the enriched frequency of 83 of 170 children (48.8%) reported in this cohort. In addition, children older than 12 years old are more likely to have been intubated due to the increased chance of intubation the longer the child has carried a diagnosis of asthma. Early childhood lower respiratory viral infections, such as human rhinovirus and respiratory syncytial virus, are implicated in the development of childhood asthma and with severe, sudden-onset asthma exacerbations (26, 27) . Complex interactions between the genetic predisposition, environmental factors, and infectious agent contribute to a dysregulated immune response, allergic sensitization, and airway colonization/infection with pathogenic bacteria. We note that pneumonia was a factor associated with increased odds of PICU admission with or without intubation. It is unclear whether early-life lower respiratory infections with injury to the airway epithelium create a proinflammatory environment in which asthma develops or whether children who wheeze with lower respiratory infections have a genetic predisposition to develop asthma and the wheezing is a marker of this susceptibility (28, 29) . Asthma exacerbations are often triggered by upper respiratory infections (URIs); however, we did not find any association with URI and a history of PICU admission. It is known that school-age children with severe asthma often have multiple allergies and a predominance of eosinophils (12) . By contrast, preschool age children with recurrent wheeze are predominantly characterized by bacterial infection and neutrophil predominance (12) . Our study focused on schoolage children, and although we saw an increase in circulating eosinophil percentage in children with critical and near-fatal asthma in univariate analysis, this factor was not significant in the final multiple variable model. We also noted higher levels of the fraction of exhaled nitric oxide in children with critical and near-fatal asthma compared with children with no prior PICU admission in univariate analysis; however, there was no association with serum IgE levels or allergen skin prick sensitization tests. In addition, we did not see an association with atopic dermatitis and allergies in our patient cohort. Exhaled nitric oxide is a marker for eosinophilic asthma that is typically suppressed by corticosteroid therapy indicating that children in our cohort may be either corticosteroid nonadherent or refractory to corticosteroid therapy.
Autopsy findings from children with fatal asthma have noted two distinct inflammatory findings, children with mucus-plugging and eosinophilic pulmonary infiltration who present with a gradual onset of respiratory failure and those children with a neutrophil-predominant pulmonary infiltration without mucus-plugging of the distal airways who present with a severe asphyxia onset of respiratory symptoms (30, 31) . Molecular phenotyping has shown that a mixed Th1 and Th2 phenotype is present in children with a severe asthma phenotype (32) , yet no such phenotyping has been undertaken in a critical asthma patient cohort. The lack of information on the airway environment and the inflammatory cells populating the critical asthmatic's airway either during an acute exacerbation or during convalescence hinders phenotyping of patients and prevents hypothesis-driven mechanistic studies and drug development that could lead to the discovery of novel therapeutic targets.
We employed a multiple variable regression analysis to our cohort of children; however, application of a nonhierarchical cluster analysis, like that undertaken by the Severe Asthma Research Program, may yield valuable insight into novel phenotypes of children with critical and near-fatal asthma (14, 24, (33) (34) (35) (36) . Although the description of children with critical and near-fatal asthma is robust and comprehensive, we did not endotype children with critical or nearfatal asthma nor did we sample or assess Th1 or Th2 airway inflammation. Cluster analysis and endotyping strategies will Figure 1 . A forest plot of adjusted odds ratios from a multiple logistic regression model for risk factors associated with PICU admission with or without endotracheal intubation compared with Never PICU admission as the reference. The adjusted odds ratios for being admitted to the PICU, but not intubated (black squares) and admitted to the PICU and intubated (gray squares) and whiskers depicting the 95% CIs are shown with never in the PICU acting as the reference.
Pediatric Critical Care Medicine www.pccmjournal.org e593 likely be more informative in the development of biologically plausible hypotheses and pharmacologic targets to prevent and intervene during a critical or near-fatal asthma exacerbation. For example, the association between a pneumonia history and critical asthma exacerbations warrants investigation into use of immunomodulatory antiinfectives, such as azithromycin, as a strategy to prevent and treat acute critical asthma exacerbations.
CONCLUSIONS
Although fatal asthma is rare, critical and near-fatal asthma are common. An in-depth individualized assessment, including endotyping, is needed to personalize the pediatric intensivists and pulmonologists approach to asthma care and prevent life-threatening outcomes. Our findings suggest that there are factors associated with critical and near-fatal asthma, distinct from the chronic asthma severity designations, that should be the focus of future investigation.
